P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
LTZ Therapeutics, Inc.
Verismo Therapeutics
University of Arizona
Mayo Clinic
University of Nebraska
Florida International University
ImmunityBio, Inc.
Nkarta, Inc.
Juno Therapeutics, a Subsidiary of Celgene
Athenex, Inc.
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Louisville
Dana-Farber Cancer Institute
University of Alabama at Birmingham
Morphotek
National Cancer Institute (NCI)
Children's Hospital of Philadelphia
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Cellerant Therapeutics
Children's Oncology Group
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Boston Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Enzon Pharmaceuticals, Inc.
Northwestern University
Northwestern University
Daiichi Sankyo